Evidence of comparative efficacy should have a formal role in European drug approvals
Sorenson, Corinna; Naci, Huseyin
; Cylus, Jonathan; and Mossialos, Elias
(2011)
Evidence of comparative efficacy should have a formal role in European drug approvals
British Medical Journal, 343 (7822).
d4849-d4849.
ISSN 0959-8138
; Cylus, Jonathan; and Mossialos, Elias
(2011)
Evidence of comparative efficacy should have a formal role in European drug approvals
British Medical Journal, 343 (7822).
d4849-d4849.
ISSN 0959-8138
Despite methodological concerns, comparative efficacy evidence should be required at the time of drug approval, says Corinna Sorenson and colleagues, to allow patients, clinicians, and other healthcare decision makers to determine whether a new drug is superior, equivalent, or inferior to its existing alternatives.
-
picture_as_pdf
Downloads